Genetic evidence for serum amyloid P component as a drug target for treatment of neurodegenerative disorders. (2023)

First Author: Schmidt AF
Attributed to:  Multimorbidity Mechanism and Therapeutics Research Collaborative funded by SPF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2023.08.15.23293564

PubMed Identifier: 37645746

Publication URI: http://europepmc.org/abstract/MED/37645746

Type: Journal Article/Review

Parent Publication: medRxiv : the preprint server for health sciences